GLOW Blend GHK-Cu 50mg / TB-500 10mg / BPC-157 10mg | NeuroPept Labs

Description

The GLOW Research Blend combines three extensively studied tissue-repair and regenerative research peptides GHK-Cu (copper tripeptide), TB-500 (Thymosin Beta-4 fragment), and BPC-157 (Body Protection Compound-157) into a single 70mg lyophilized research compound. Each peptide in this blend acts through complementary and distinct biological pathways, making this combination a valuable tool for researchers studying multi-pathway tissue repair, extracellular matrix remodelling, angiogenesis, and wound healing biology.

NeuroPept Labs supplies the GLOW Blend 70mg as a research-grade lyophilized peptide intended strictly for in vitro laboratory and analytical research use. All batches are synthesised under controlled conditions and verified through third-party analytical testing. COA validity can be confirmed at freedomdiagnosticstesting.com using the Accession Number, Client ID, or Search Code found in the product images.

Individual Peptide Mechanisms (Research Overview)

GHK-Cu Copper Tripeptide

GHK-Cu (Gly-His-Lys complexed with copper II ion) is a naturally occurring tripeptide with demonstrated activity in collagen synthesis, angiogenesis, and wound contraction research models. Its biological effects are studied across dermal, neural, and hepatic tissue contexts:

• Collagen and elastin synthesis stimulates fibroblast production of collagen types I and III and elastin in dermal repair models
• Angiogenesis promotes VEGF-mediated neovascularisation and capillary network formation in wound repair studies
• Anti-inflammatory signalling modulates NF-ÃŽºB pathway activity and TNF-ÃŽ± expression in inflammatory response models
• Gene expression regulation GHK-Cu has been shown to modulate over 4,000 human genes in microarray studies, including genes involved in tissue remodelling, stem cell activation, and antioxidant defence
• Wound contraction enhances dermal wound healing rates and scar tissue remodelling in preclinical models

TB-500 Thymosin Beta-4 Synthetic Fragment

TB-500 is a synthetic peptide fragment derived from Thymosin Beta-4 (TÃŽ²4), a naturally occurring 43-amino acid protein involved in actin regulation, cell migration, and tissue repair. TB-500 retains the critical LKKTETQ actin-binding domain of TÃŽ²4:

• Actin sequestration and cytoskeletal regulation binds G-actin monomers, regulating actin polymerisation dynamics critical for cell migration and tissue repair
• Angiogenesis and endothelial cell migration promotes endothelial cell movement and tubulogenesis for neovascularisation in healing tissue
• Stem cell recruitment studied for activation and mobilisation of progenitor cells to sites of tissue injury
• Anti-inflammatory and anti-fibrotic effects reduces inflammatory cytokine profiles and fibrotic tissue deposition in cardiac and musculoskeletal models
• Low molecular weight and systemic distribution its small size enables broad tissue distribution in research models

BPC-157 Body Protection Compound 157

BPC-157 is a synthetic pentadecapeptide (15 amino acids) derived from a protective gastric protein. It is among the most studied research peptides for gastrointestinal, musculoskeletal, and vascular repair:

• Gastrointestinal cytoprotection studied for gut lining integrity, ulcer healing, and GI tissue repair in rodent models
• Tendon and ligament repair promotes fibroblast migration and tendon explant outgrowth in musculoskeletal repair studies
• Angiogenesis via VEGFR2 upregulation enhances formation of new blood vessels at injury sites through growth factor receptor pathways
• Nitric oxide (NO) pathway modulation interacts with the NO system to regulate vascular tone and tissue blood flow in healing models
• Neuroprotective research emerging studies examine BPC-157 in CNS models for dopaminergic pathway preservation and neuroinflammation reduction

Why a Blend? Research Rationale

The complementary receptor targets and tissue distribution profiles of these three peptides make them a logical subject for combination research protocols where multi-pathway tissue repair signalling is under investigation.

Product Specifications

Storage and Handling

• Store lyophilized blend at -20°C or below prior to reconstitution
• Avoid repeated freeze-thaw cycles to preserve structural integrity of all three peptide components
• Protect from direct light, humidity, and room temperature exposure
• Reconstitute using sterile bacteriostatic water under aseptic conditions
• Once reconstituted, store at 4°C and use within recommended research timeframes

Frequently Asked Questions

What is the GLOW peptide blend?

The GLOW blend is a research-grade combination of three distinct peptides GHK-Cu (copper tripeptide), TB-500 (Thymosin Beta-4 fragment), and BPC-157 (Body Protection Compound-157) in a single 70mg lyophilized vial. Each component acts through complementary biological pathways studied in tissue repair, angiogenesis, extracellular matrix remodelling, and wound healing research.

What does GHK-Cu do in research?

GHK-Cu is a copper tripeptide studied for its role in stimulating collagen and elastin synthesis, promoting angiogenesis via VEGF pathways, modulating NF-ÃŽºB anti-inflammatory signalling, and regulating over 4,000 human genes involved in tissue remodelling and stem cell activation.

What is TB-500 and how is it different from Thymosin Beta-4?

TB-500 is a synthetic peptide fragment containing the LKKTETQ actin-binding sequence of Thymosin Beta-4 (TÃŽ²4). It retains TÃŽ²4’s core functional domain for actin sequestration, cell migration, and angiogenesis while offering a lower molecular weight compound for research use. TB-500 is not identical to full-length TÃŽ²4 but shares its primary mechanistic axis.

Why are BPC-157, TB-500, and GHK-Cu studied together?

The three peptides act through distinct but complementary pathways GHK-Cu addresses extracellular matrix and collagen synthesis, TB-500 targets cytoskeletal regulation and cell migration, and BPC-157 focuses on vascular repair and gastrointestinal cytoprotection. Research combining all three examines potential additive or synergistic effects across multi-tissue repair pathways.

Scientific References

1. GHK-Cu, BPC-157 and TB-500: What They Reveal About Tissue Repair Research Simple Peptide 2025
2. Therapeutic Peptides: Current Applications and Future Directions PMC/NIH 2022
3. Peptides as Therapeutic Agents: Challenges and Opportunities PMC/NIH 2023

Research Use Disclaimer: All products sold by NeuroPept Labs are intended strictly for in vitro laboratory research and scientific investigation by qualified professionals. They are not approved for human consumption, medical treatment, or veterinary use. Purchasers are responsible for compliance with applicable regulations in their jurisdiction.